Correspondence 0001104659-24-058000 from Elevation Oncology, Inc. (ELEV) (CIK 0001783032)
Elevation Oncology, Inc. (ELEV) (CIK 0001783032)
Date: May 7, 2024 · CIK: 0001783032 · Accession: 0001104659-24-058000
AI Filing Summary & Sentiment
File numbers found in text: 333-279053
Letter
ELEVATION ONCOLOGY, INC.
101 Federal Street., Suite 1900
Boston, MA 02110
May 7, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, DC 20549
Attention: Jason Drory
Re: Elevation Oncology, Inc. Registration Statement on Form S-3 (File No. 333-279053) filed May 2, 2024.
Requested Date: May 9, 2024
Requested Time: 4:00 PM Eastern Time
Ladies and Gentlemen:
Elevation Oncology, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission.
The Registrant hereby authorizes Rob Freedman and Ryan Mitteness, both of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to Mr. Freedman at (650) 335-7292 or, in his absence, to Mr. Mitteness at (206) 389-4533.
* * *
Sincerely,
ELEVATION
ONCOLOGY, INC.
Show Raw Text
CORRESP
1
filename1.htm
ELEVATION ONCOLOGY, INC.
101 Federal Street., Suite 1900
Boston, MA 02110
May 7, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, DC 20549
Attention:
Jason Drory
Re:
Elevation Oncology, Inc. Registration Statement on Form S-3
(File No. 333-279053) filed May 2, 2024.
Requested Date: May 9, 2024
Requested Time: 4:00 PM Eastern Time
Ladies and Gentlemen:
Elevation Oncology, Inc.
(the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”)
take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested
Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Registrant
may orally request via telephone call to the staff of the Commission.
The
Registrant hereby authorizes Rob Freedman and Ryan Mitteness, both of whom are attorneys with the Registrant’s outside legal
counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.
The Registrant requests that
it be notified of such effectiveness by a telephone call to Mr. Freedman at (650) 335-7292 or, in his absence, to Mr. Mitteness
at (206) 389-4533.
* * *
Sincerely,
ELEVATION
ONCOLOGY, INC.
By:
/s/
Tammy Furlong
Tammy Furlong, Chief Financial Officer
Cc Joseph J. Ferra, Jr., President and Chief Executive Officer
Elevation Oncology, Inc.
Rob Freedman, Esq.
Ryan Mitteness, Esq.
Fenwick & West LLP
[Signature Page to Company Acceleration Request
Letter]